Follow Us
© 2026 Arizent. All rights reserved.
Payments from drugmakers and medical device companies to doctors must be disclosed to the U.S. government beginning next March, regulators said last week.
The Patient Protection and Affordable Care Act requires the companies to report their payments to physicians for help with research, speaking engagements and other activities. The government will begin disclosing the payments on a public website by Sept. 30, 2014, according to the new rules.
For reprint and licensing requests for this article, click here.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Reimbursing employees for physician-authorized medical cannabis gains traction as an alternative to costly pharmaceuticals.
Three-quarters of employees say they work more than 40 hours a week, as employer expectations, economic pressure and blurred work boundaries fuel overwork.
Inclusive benefit design builds trust, drives preventive utilization and replaces reactive cost-shifting with proactive value creation.
CannaLnx, a new digital health platform, connects doctors, insurers and dispensaries as employers begin adding reimbursable medical cannabis to workplace benefit plans.
